SciQuest, which landed Aventis as a customer recently, added another biotechnology company as a client on Tuesday.
Although SciQuest did not name the customer, it described the firm as a “top 10 biotechnology company.” SciQuest said the multi-year contract calls for the biotech firm to utilize its Spend Director and Order Manager software products.
SciQuest stock rose 4 cents Tuesday to close at $4.16. The company executed a 7.5-for-1 reverse stock merger on May 20. Its stock was selling for 56 cents on May 9.